T-NHL

A Multicenter, Open-Label Trial of Belinostat in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

PXD101-CLN-19, Belinostat

EudraCT-Nr.: 2008-005843-40

Sponsor: TopoTarget A/S, Symbion, 3 Fruebjergvej, DK-2100 Kopenhagen, Dänemark

LKP: PD Dr. Andreas Viardot

Prüfärzte: Prof. Dr. Stephan Stilgenbauer, Dr. Dirk Winkler, Dr. Andreas Bühler, Dr. Regine Mayer-Steinacker

Dokumentation: Silke Merkel, Sigrid Weitzel, CenTrial GmbH

Alemtuzumab and Chemotherapy in T-cell-Lymphoma (ACT):
CHOP-14 with or without the Monoclonal Anti-CD52 Antibody Alemtuzumab in Elderly Patients

DSHNHL 2006-1B /ACT-2

EudraCT-Nr.: 2007-000821-23

Sponsor: Prof. Dr. med. L. Trümper, Göttingen

LKP: Prof. Dr. med. L. Trümper, Göttingen

Hauptprüfer: PD Dr. Andreas Viardot

Prüfärzte: Prof. Dr. Stephan Stilgenbauer, Dr. Dirk Winkler, Dr. Jennifer Edelmann

Dokumentation:  Dietmar Henle, Daniela Hermsdorf